Literature DB >> 33742010

Cryogenic cave carbonate and implications for thawing permafrost at Winter Wonderland Cave, Utah, USA.

Jeffrey Munroe1, Kristin Kimble2, Christoph Spötl3, Gabriela Serrato Marks4, David McGee4, David Herron5.   

Abstract

Winter Wonderland Cave contains perennial ice associated with two types of cryogenic cave carbonate (CCC) formed during the freezing of water. CCCfine is characterized by relatively high δ13C values, whereas CCCcoarse exhibits notably low δ18O values indicating precipitation under (semi)closed-system conditions in a pool of residual water beneath an ice lid. Previous work has concluded that CCCcoarse forms during permafrost thaw, making the presence of this precipitate a valuable indicator of past cryospheric change. Available geochronologic evidence indicates that CCC formation in this cave is a Late Holocene or contemporary process, and field observations suggest that the cave thermal regime recently changed in a manner that permits the ingress of liquid water. This is the first documented occurence of CCCcoarse in the Western Hemisphere and one of only a few locations where these minerals have been found in association with ice. Winter Wonderland Cave is a natural laboratory for studying CCC genesis.

Entities:  

Year:  2021        PMID: 33742010     DOI: 10.1038/s41598-021-85658-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  3 in total

1.  Continuous-flow isotope ratio mass spectrometric analysis of carbonate minerals.

Authors:  Christoph Spötl; Torsten W Vennemann
Journal:  Rapid Commun Mass Spectrom       Date:  2003       Impact factor: 2.419

2.  Long-term performance of the Gasbench isotope ratio mass spectrometry system for the stable isotope analysis of carbonate microsamples.

Authors:  Christoph Spötl
Journal:  Rapid Commun Mass Spectrom       Date:  2011-06-15       Impact factor: 2.419

3.  Speleothems reveal 500,000-year history of Siberian permafrost.

Authors:  A Vaks; O S Gutareva; S F M Breitenbach; E Avirmed; A J Mason; A L Thomas; A V Osinzev; A M Kononov; G M Henderson
Journal:  Science       Date:  2013-02-21       Impact factor: 47.728

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.